Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review

被引:18
作者
Mahendiratta, Saniya [1 ]
Bansal, Seema [2 ]
Sarma, Phulen [1 ]
Kumar, Harish [1 ]
Choudhary, Gajendra [1 ]
Kumar, Subodh [3 ]
Prakash, Ajay [1 ]
Sehgal, Rakesh [4 ]
Medhi, Bikash [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pharmacol, Res Block B,Room 4044 4th Floor, Chandigarh, India
[2] Post Grad Inst Med Educ & Res, Chandigarh, India
[3] PGIMER, Chandigarh, India
[4] Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh, India
关键词
SARS-CoV-2; Stem cell therapy; ARDS; Immunomodulatory; Coronavirus; ACUTE LUNG INJURY; MESENCHYMAL STROMAL CELLS; TRANSPLANTATION; COLI;
D O I
10.1016/j.biopha.2021.111300
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: SARS-CoV-2, which majorly affects the lungs and respiratory tract is thought due to dysregulation of the immune system which causes an immense imbalance of the cytokines. However, till now no standard treatment has been developed in treating the disease. On the other hand, it becomes important to prevent the acute respiratory tract infection due to COVID-19 which is the most dangerous phase leading to increased mortality. Hence this systematic review has been framed by pooling the available data of the use of stem cells in SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS. Methods: 6 literature databases (PubMed, EMBASE, Scopus, Google Scholar, Clinicaltrials.gov, and Clinical trial registry of India) were searched for relevant studies till 10th August 2020 using keywords stem cells, mesen-chymal stem cells, cell therapy, SARS CoV-2, SARS Coronavirus, Coronavirus 2, COVID-19, nCoV-19, Novel Coronavirus, MERS CoV, ARDS, acute respiratory distress syndrome. Results: The observations of this systematic review suggest capability of MSCs in reducing the systemic inflam-mation and protecting against SARS-CoV-2 as evidenced by the available clinical data. Conclusion: MSCs can overcome the clinical challenges currently faced by SARS-CoV-2 infected patients, spe-cifically who are seriously ill and not responding to conventional therapies. Though the available clinical data is motivating, still predicting the therapeutic potential of MSCs will be too early in COVID-19. Hence, further studies in a larger cohort of patients becomes a prerequisite to validate their potential efficacy.
引用
收藏
页数:15
相关论文
共 87 条
  • [71] Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential
    Volarevic, Vladislav
    Gazdic, Marina
    Markovic, Bojana Simovic
    Jovicic, Nemanja
    Djonov, Valentin
    Arsenijevic, Nebojsa
    [J]. BIOFACTORS, 2017, 43 (05) : 633 - 644
  • [72] Factors secreted from dental pulp stem cells show multifaceted benefits for treating acute lung injury in mice
    Wakayama, Hirotaka
    Hashimoto, Naozumi
    Matsushita, Yoshihiro
    Matsubara, Kohki
    Yamamoto, Noriyuki
    Hasegawa, Yoshinori
    Ueda, Minoru
    Yamamoto, Akihito
    [J]. CYTOTHERAPY, 2015, 17 (08) : 1119 - 1129
  • [73] Wang F.-S., 2020, REPORT NO NCT0425211
  • [74] Wang Phase F.-S.A., 2020, REPORT NO NCT0428810
  • [75] Forty years with coronaviruses
    Weiss, Susan R.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2020, 217 (05)
  • [76] Wilson JG, 2015, LANCET RESP MED, V3, P24, DOI [10.1016/S2213-2600(14)70291-7, 10.1016/s2213-2600(14)70291-7]
  • [77] Quantifying the relative contribution of particulate versus dissolved silver to toxicity and uptake kinetics of silver nanowires in lettuce: impact of size and coating
    Wu, Juan
    Yu, Qi
    Bosker, Thijs
    Vijver, Martina G.
    Peijnenburg, Willie J. G. M.
    [J]. NANOTOXICOLOGY, 2020, 14 (10) : 1399 - 1414
  • [78] Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells Promotes the Repair of LPS-Induced Acute Lung Injury
    Xiang, Bingyu
    Chen, Lu
    Wang, Xiaojun
    Zhao, Yongjia
    Wang, Yanling
    Xiang, Charlie
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (04):
  • [79] Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
    Xiao, Kun
    Hou, Fei
    Huang, Xiuyu
    Li, Binbin
    Qian, Zhi Rong
    Xie, Lixin
    [J]. STEM CELL RESEARCH & THERAPY, 2020, 11 (01)
  • [80] Xie, HEPATOL BALTIM MD, V2, P820